Opioids Market Scope And Analysis

Report Code : TIPRE00004770
Category : Pharmaceuticals

Status : Published
No. of Pages : 209

Buy Now

Opioids Market Analysis and Scope (2024 to 2031)

Buy Now

Opioids Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 12.93 Billion
Market Size by 2031	US$ 15.03 Billion
Global CAGR (2023 - 2031)	1.9%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Product Immediate-Release Short-Acting Opioids Extended-Release Long-Acting Opioid By Application Pain Management Anaesthesia Diarrhoea Suppression Cough Suppression De-Addiction By Route Of Administration Oral Injectable Transdermal Patch By Distribution Channel Hospital Pharmacies Retail Pharmacies
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Purdue Pharma LP Endo International plc Mallinckrodt Plc Collegium Pharmaceutical Inc Neuraxpharm Pharmaceuticals SL Hikma Pharmaceuticals Plc Mayne Pharma Group LtD Rusan Pharma Ltd Trevena Inc Teva Pharmaceutical Industries Ltd

Opioids Market News and Recent Developments

The opioids market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments and strategies in the opioids market:

In March 2023, Trevena, Inc. announced that Jiangsu Nhwa Pharmaceutical Co., its partner in China, received formal approval from the National Medical Products Administration for OLINVYK. It has been approved for use in adults for the management of acute pain that is severe enough to require an intravenous opioid analgesic and is resistant to alternative treatments. (Source: Trevena, Inc., Press Release, 2023)
In January 2023, Neuraxpharm announced the establishment of Neuraxpharm Belgium to cover Belgium and Luxembourg, completing its presence in Benelux as it continues its expansion pathway in Europe. (Source: Neuraxpharm, Press Release, 2023)
In February 2023, Neuraxpharm announced the acquisition of two established product portfolios for central nervous system (CNS) disorders, and pain and vascular diseases from Sanofi. The well-established products that Neuraxpharm acquired include 15 products addressing CNS disorders and 2 products in pain and vascular diseases. (Source: Neuraxpharm, Press Release, 2023)

Opioids Market Report Coverage and Deliverables

The “Opioid Market Size and Forecast (2023–2031)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST and SWOT analyses
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments.
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments.
Detailed company profiles